Atlas Trials

Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis

Clinical trial NCT07491016 · RECRUITING

Trial details

NCT number
NCT07491016
Sponsor
Zhejiang Provincial People's Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
TelitaciceptTreatment ComplianceRheumatoid Arthritis
Start date
2026-03-01
Primary completion
2027-03-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.